医疗科技公司Privia Health Group, Inc.（纳斯达克股票代码：PRVA）今日盘前股价大涨5.06%，投资者对公司发布的2025年第二季度财务业绩报告反应积极。
根据公司公布的财报，Privia Health在第二季度实现了多项关键指标的显著增长。总收入同比增长23.4%至5.212亿美元，非GAAP调整后净利润增长30.1%至3,060万美元。公司的实施医疗服务提供者数量较去年同期增长13.8%，达到5,125名，诊所收入增长18.5%至8.629亿美元。值得注意的是，公司的调整后EBITDA同比增长31.6%至2,900万美元，展现了强劲的盈利能力。
更令市场振奋的是，Privia Health上调了2025财年的全年指引。公司预计诊所收入、GAAP收入、平台贡献和调整后EBITDA都将超过此前指引的高端水平。这一乐观展望反映了管理层对公司业务持续增长的信心，也是推动股价上涨的重要因素。公司CEO Shawn Morris表示："我们在所有关键运营和财务指标上均表现出色，这证明了我们的业务模式的韧性和可扩展性。"
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.